Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Zoetis Inc. A Stock

Price
Target price
€109.26

€109.26

0.650%
0.7
0.650%
€161.39
 
20.02.26 / Tradegate WKN: A1KBYX / Symbol: ZTS / Name: Zoetis / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Zoetis Inc. A in the next few years
Wizard

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Zoetis Inc. A is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Zoetis

sharewise wants to provide you with the best news and tools for Zoetis, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

Should You Buy Zoetis Before Feb. 12?: https://g.foolcdn.com/editorial/images/854276/veterinarian-cat-sick-pet-health-1200x800-5b2df79.jpg
Should You Buy Zoetis Before Feb. 12?

Zoetis (NYSE: ZTS) tanked after its November earnings release. Will history repeat itself pre-market on Feb. 12, when the animal healthcare company releases results for the fourth quarter of 2025

TheMotleyFool 
0 09.02.26
2 Healthcare Stocks Poised for a Comeback in 2026: https://g.foolcdn.com/editorial/images/850296/pet-owners-walking-their-dog.jpg
2 Healthcare Stocks Poised for a Comeback in 2026

Zoetis (NYSE: ZTS) and Regeneron Pharmaceuticals (NASDAQ: REGN) are two healthcare leaders that have lagged broader equities over the past 12 months, as both encountered headwinds that led to

TheMotleyFool 
0 22.01.26
This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years: https://g.foolcdn.com/editorial/images/850938/gettyimages-2162484566.jpg
This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years

For the first 10 years of its publicly traded life, leading animal healthcare stock Zoetis (NYSE: ZTS) easily outpaced the S&P 500, rising 480% and doubling the index's total returns. However, since

TheMotleyFool 
0 22.01.26
These 2 Healthcare Stocks Just Declared Dividend Raises: https://g.foolcdn.com/editorial/images/847235/person-checking-medicine-on-a-shelf-in-a-pharmacy.jpg
These 2 Healthcare Stocks Just Declared Dividend Raises

While the pre-holiday season isn't usually a busy time for dividend raises, investors can usually expect a few companies to end the year on a high note by declaring one.

Sure enough, in the fading

TheMotleyFool 
0 17.12.25
2 Stocks to Buy Near Their 52-Week Lows: https://g.foolcdn.com/editorial/images/844124/person-using-a-smartphone.jpg
2 Stocks to Buy Near Their 52-Week Lows

Recent developments have led to significant declines in the stock prices of Pinterest (NYSE: PINS) and Zoetis (NYSE: ZTS). Due to company-specific issues, both are currently not that far from their

TheMotleyFool 
0 01.12.25
Zoetis: A Solid Investment in the Growing Pet Medicine Market?
Zoetis: A Solid Investment in the Growing Pet Medicine Market?

Explore the exciting world of Zoetis (NYSE: ZTS) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends

TheMotleyFool 
0 03.10.25